(Total Views: 482)
Posted On: 03/12/2020 11:50:02 PM
Post# of 154897
“When new investors are given the opportunities to read such peer reviews of Pro 140 they get a chance to answer the old age question....”
To be clear, the article today by Targeted Oncology was not peer reviewed but instead a summary of today’s PR and leronlimab’s progress in mTNBC.
To be clear, the article today by Targeted Oncology was not peer reviewed but instead a summary of today’s PR and leronlimab’s progress in mTNBC.
(0)
(0)
